Contribution of perfusion magnetic resonance imaging in a patient with cerebral ganglioglioma;Intérêt de l'imagerie par résonance magnétique de perfusion: À propos d'un cas de gangliogliome cérébral

Neurochirurgie

Volumn 48, Issue 5, 2002, Pages 426-430

  Metellus P ^a,d   Ameur, A Ait ^b   Faillot, T ^a   Camparo, P ^c   Dutertre, G ^a   Desgeorges, M ^a  

^a Hop d'Instruct Armees Val de Grace   (France)

^b Service de Neuroradiologie   (France)

^c Hop d'Instruct Armees Val de Grace   (France)

^d TIMONE HOSPITAL   (France)

Author keywords

Cerebral ganglioglioma; Magnetic resonance imaging

Indexed keywords

GADOLINIUM;

ADULT; ARTICLE; BRAIN BLOOD VOLUME; BRAIN MAPPING; BRAIN TUMOR; CASE REPORT; CONTRAST ENHANCEMENT; FEMALE; FRONTAL LOBE; GLIOMA; HISTOPATHOLOGY; HUMAN; NEUROLOGIC EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PREOPERATIVE EVALUATION;

DIAGNOSIS, DIFFERENTIAL; EPILEPSIES, PARTIAL; FEMALE; FRONTAL LOBE; GADOLINIUM; GANGLIOGLIOMA; HUMANS; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; OLIGODENDROGLIOMA; RADIOPHARMACEUTICALS; SENSITIVITY AND SPECIFICITY; SUPRATENTORIAL NEOPLASMS;

EID: 0036854360     PISSN: 00283770     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Aronen HJ, Gazit IE, Louis DN, Buchbinder BR, Pardo FS, Weisskoff RM, et al. Cerebral blood volume maps of gliomas: Comparison with tumor grade and histologic findings. Radiology 1994; 191: 41-51.
2. Aronen HJ, Glass J, Pardo FS, Belliveau JW, Gruber ML, Buchbinder BR, et al. Echo-planar MR cerebral blood volume mapping of gliomas. Clinical utility. Acta Radiol 1995; 36: 520-528.
3. Aronen HJ, Pardo FS, Kennedy DN, Belliveau JW, Packard SD, Hsu DW, et al. High microvascular blood volume is associated with high glucose uptake and tumor angiogenesis in human gliomas. Clin Cancer Res 2000; 6: 2189-2200.
4. Bryan RN, McLaughlin A. MR perfusion imaging. AJNR Am J Neuroradiol 1999; 20: 1192-1193.
5. Daumas-Duport C, Beuvon F, Varlet P, FalletBianco C. [Gliomas: WHO and Sainte-Anne Hospital classifications]. Ann Pathol 2000; 20: 413-428.
6. Gray L, MacFall J. Overview of diffusion imaging. Magn Reson Imaging Clin North Am 1998; 6: 125-138.
7. Kleihues P, Burger PC, Scheithauer BW. The new WHO classification of brain tumours. Brain Pathol 1993; 3: 255-268.
8. Knopp EA, Cha S, Johnson G, Mazumdar A, Golfinos JG, Zagzag D, et al. Glial neoplasms: Dynamic contrast-enhanced T2*-weighted MR imaging. Radiology 1999; 211: 791-798.
9. Maeda M, Itoh S, Kimura H, Iwasaki T, Hayashi N, Yamamoto K, et al. Tumor vascularity in the brain: Evaluation with dynamic susceptibility-contrast MR imaging. Radiology 1993; 189: 233-238.
10. Roberts HC, Roberts TP, Brasch RC, Dillon WP. Quantitative measurement of microvascular permeability in human brain tumors achieved using dynamic contrast-enhanced MR imaging: Correlation with histologic grade. AJNR Am J Neuroradiol 2000; 21: 891-899.
11. Sugahara T, Korogi Y, Kochi M, Ikushima I, Hirai T, Okuda T, et al. Correlation of MR imaging-determined cerebral blood volume maps with histologic and angiographic determination of vascularity of gliomas. AJR Am J Roentgenol 1998; 171: 1479-1486.
12. Wong ET, Jackson EF, Hess KR, Schomer DF, Hazle JD, Kyritsis AP, et al. Correlation between dynamic MRI and outcome in patients with malignant gliomas. Neurology 1998; 50: 777-781.
13. Wong JC, Provenzale JM, Petrella JR. Perfusion MR imaging of brain neoplasms. AJR Am J Roentgenol 2000; 174: 1147-1157.